NCT07533006 clinical trial report covering LY-4005130, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07535034 clinical trial report covering Dotinurad, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07534332 clinical trial report covering Disulfiram, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07533942 clinical trial report covering Zeltiprone, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07537699 clinical trial report covering Dexamethasone Sodium Phosphate, Phase 2, endpoints, sponsor, geography, readout timing and development white spa

NCT07537673 clinical trial report covering Dexamethasone Sodium Phosphate, Phase 2, endpoints, sponsor, geography, readout timing and development white spa

NCT07537660 clinical trial report covering Dexamethasone Sodium Phosphate, Phase 2, endpoints, sponsor, geography, readout timing and development white spa

ChiCTR2600122789 clinical trial report covering Sintilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07535762 clinical trial report covering Cyclophosphamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07536269 clinical trial report covering Crinecerfont, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07536789 clinical trial report covering Becotatug vedotin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07537777 clinical trial report covering Anlotinib Dihydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.